Some of their considerations include: If you are eligible for Primary Care If you are enrolled in one of our Condition Management programs and your plan includes virtual care If youve tried to lose weight through lifestyle changes but have not been successful GLP-1 medications are not available through 24/7 Care (General Medical)
This approach ensures each active ingredient gets to work without any interference and gives your skin ample time to recover
The second category included substances considered too risky for compounding
Four specific conditions qualify for Tier 3 (BMI 27 or higher): (1) prediabetes per American Diabetes Association criteria (typically A1c 5.7 to 6.4 percent, fasting glucose 100 to 125, or 2-hour oral glucose tolerance test 140 to 199), (2) previous heart attack (myocardial infarction), (3) previous stroke, and (4) symptomatic peripheral artery disease
Vomiting is less common than nausea, but some users may experience it
Summary For GLP-1-class research, compound selection depends on which receptor pathways are most relevant to study objectives: Mazdutide: Dual GLP-1/glucagon for glucagon-specific pathway research without GIP Tirzepatide: Dual GLP-1/GIP with FDA approval and extensive published literature Retatrutide: Triple agonist for comprehensive multi-pathway research All three compounds are available at research-grade quality from PeptideStack